EU nod for opioid dependence therapy by Selina McKee | Nov 21, 2017 | News | 0 The European Medicines Agency has issued a marketing authorisation for Orexo and MundiPharma’s Zubsolv (buprenorphine and naloxone) for opioid dependence. Read More
CHMP backs 13 treatments for EU approval by Selina McKee | Sep 18, 2017 | News | 0 Thirteen new therapies – including two biosimilars – have been backed for approval in Europe. Read More
MundiPharma, Orexo file Zubsolv in Europe by Selina McKee | Oct 4, 2016 | News | 0 UK-based MundiPharma and Swedish group Orexo’s have filed opioid dependence drug Zubsolv in Europe. Read More